View in EDS HTML Full Text PDF Full Text

LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.

Saved in:
Bibliographic Details
Title: LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.
Authors: Serra-Bardenys G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Institut Bonanova FP Sanitaria, Consorci Mar Parc de Salut de Barcelona, Spain., Blanco E; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain., Escudero-Iriarte C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Serra-Camprubí Q; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Querol J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Pascual-Reguant L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain., Morancho B; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Escorihuela M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Tissera NS; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Sabé A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Martín L; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Segura-Bayona S; The Francis Crick Institute, London, UK., Verde G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Aiese Cigliano R; Sequentia Biotech SL, Barcelona, Spain., Millanes-Romero A; Institute for Research in Biomedicine (IRB Barcelona) and Barcelona Institute of Science and Technology, Spain., Jerónimo C; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institut de Recherches Cliniques de Montréal, Canada., Cebrià-Costa JP; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Simonetti S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Viaplana C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Oliveira M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Peg V; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain., Stracker TH; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA., Arribas J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Canals F; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Villanueva J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Di Croce L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., García de Herreros A; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain., Tian TV; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Peiró S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Source: The FEBS journal [FEBS J] 2024 Jun; Vol. 291 (11), pp. 2423-2448. Date of Electronic Publication: 2024 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1742-4658
DOI:10.1111/febs.17112